0001179110-13-013542.txt : 20130827
0001179110-13-013542.hdr.sgml : 20130827
20130827173613
ACCESSION NUMBER: 0001179110-13-013542
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20130823
FILED AS OF DATE: 20130827
DATE AS OF CHANGE: 20130827
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AASTROM BIOSCIENCES INC
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 24 FRANKL LLOYD WRIGHT DR
STREET 2: PO BOX 376
CITY: ANN ARBOR
STATE: MI
ZIP: 48106
BUSINESS PHONE: 7349305555
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Elliston Michael W.
CENTRAL INDEX KEY: 0001585205
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 131063712
MAIL ADDRESS:
STREET 1: AASTEROM BIOSCIENCES, INC.
STREET 2: 24 FRANK LLOYD WRIGHT DRIVE
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
3
1
edgar.xml
FORM 3 -
X0206
3
2013-08-23
0
0000887359
AASTROM BIOSCIENCES INC
ASTM
0001585205
Elliston Michael W.
C/O AASTROM BIOSCIENCES, INC.
P.O. BOX 376
ANN ARBOR
MI
48106
0
1
0
0
Controller
Stock Option (right to buy)
1.86
2021-12-20
Common Stock
100000
D
Stock Option (right to buy)
2.49
2022-05-03
Common Stock
50000
D
These options were granted on December 20, 2011 with 25% vesting on the first anniversary of the date of grant and 6.25% vesting each quarter thereafter.
These options were granted on May 3, 2012 and vest quarterly over four years commencing on the date of grant.
/s/ Dominick C. Colangelo, attorney-in-fact
2013-08-27
EX-24.EXHIBIT 24
2
poaelliston.txt
POWER OF ATTORNEY
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
Know all by these presents, that the undersigned's hereby
makes, constitutes and appoints each of Dominick Colangelo and
Mitchell S. Bloom as the undersigned's true and lawful attorney-
in-fact, with full power and authority as hereinafter described
on behalf of and in the name, place and stead of the undersigned
to:
(1) prepare, execute, acknowledge, deliver and file Forms 3, 4,
and 5 (including any amendments thereto) with respect to the
securities of Aastrom Biosciences, Inc., a Michigan corporation
(the "Company"), with the United States Securities and Exchange
Commission, any national securities exchanges and the Company, as
considered necessary or advisable under Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations
promulgated thereunder, as amended from time to time (the
"Exchange Act");
(2) seek or obtain, as the undersigned's representative and on
the undersigned's behalf, information on transactions in the
Company's securities from any third party, including brokers,
employee benefit plan administrators and trustees, and the
undersigned hereby authorizes any such person to release any such
information to the undersigned and approves and ratifies any such
release of information; and
(3) perform any and all other acts which in the discretion of
such attorney-in-fact are necessary or desirable for and on
behalf of the undersigned in connection with the foregoing.
The undersigned acknowledges that:
(1) this Power of Attorney authorizes, but does not require, such
attorney-in-fact to act in his or her discretion on information
provided to such attorney-in-fact without independent
verification of such information;
(2) any documents prepared and/or executed by such attorney-in-
fact on behalf of the undersigned pursuant to this Power of
Attorney will be in such form and will contain such information
and disclosure as such attorney-in-fact, in his or her
discretion, deems necessary or desirable;
(3) neither the Company nor such attorney-in-fact assumes (i) any
liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the
undersigned for any failure to comply with such requirements, or
(iii) any obligation or liability of the undersigned for profit
disgorgement under Section 16(b) of the Exchange Act; and
(4) this Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations
under the Exchange Act, including without limitation the
reporting requirements under Section 16 of the Exchange Act.
The undersigned hereby gives and grants the foregoing
attorney-in-fact full power and authority to do and perform all
and every act and thing whatsoever requisite, necessary or
appropriate to be done in and about the foregoing matters as
fully to all intents and purposes as the undersigned might or
could do if present, with full power of substitution or
revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of
this Power of Attorney and the rights and powers herein granted.
This Power of Attorney shall remain in full force and effect
until revoked by the undersigned in a signed writing delivered to
such attorney-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 24th day of August,
2013.
/s/ Michael W. Elliston
________________________________
Signature
Michael W. Elliston
_________________________________
Print Name